Correlation Between CSL and Cell Source
Can any of the company-specific risk be diversified away by investing in both CSL and Cell Source at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Cell Source into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL and Cell Source, you can compare the effects of market volatilities on CSL and Cell Source and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Cell Source. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Cell Source.
Diversification Opportunities for CSL and Cell Source
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CSL and Cell is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding CSL and Cell Source in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cell Source and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with Cell Source. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cell Source has no effect on the direction of CSL i.e., CSL and Cell Source go up and down completely randomly.
Pair Corralation between CSL and Cell Source
Assuming the 90 days horizon CSL is expected to generate 5.04 times less return on investment than Cell Source. But when comparing it to its historical volatility, CSL is 9.33 times less risky than Cell Source. It trades about 0.31 of its potential returns per unit of risk. Cell Source is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 29.00 in Cell Source on April 27, 2025 and sell it today you would earn a total of 11.00 from holding Cell Source or generate 37.93% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
CSL vs. Cell Source
Performance |
Timeline |
CSL |
Cell Source |
CSL and Cell Source Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CSL and Cell Source
The main advantage of trading using opposite CSL and Cell Source positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Cell Source can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Source will offset losses from the drop in Cell Source's long position.CSL vs. CSL Limited | CSL vs. Pmv Pharmaceuticals | CSL vs. Novo Nordisk AS | CSL vs. Kalvista Pharmaceuticals |
Cell Source vs. RenovaCare | Cell Source vs. Nutriband | Cell Source vs. Lixte Biotechnology Holdings | Cell Source vs. Quizam Media |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |